Workshop on antimicrobial resistance concludes
Islamabad
March 4, 2021
Islamabad : A two-day consultative workshop focusing on the basic concepts of Antimicrobial Resistance (AMR), its severity, and methods to estimate AMR concluded here Wednesday, with the staff of the Drug Regulatory Authority of Pakistan (DRAP) and other regional provincial regulatory bodies benefiting from the capacity-building activity.
Organised by the UK aid-funded Fleming Fund Country Grant-DAI, the workshop was arranged to apprise the participants of the importance of AMR and the stewardship programmes that can be established to cope with issues related to AMR.
In addition to the Chief Executive Officer of DRAP Asim Rauf, the workshop was addressed by Dr. Ayesha Rasheed, Team Lead of Fleming Fund Country Grant-DAI, Hafiz Alam Sher from the Provincial Pharmacovigilance Center, Punjab, Dr. Zikriya Saleem from the University of Lahore, and Dr. Huma Qureshi.
Workshop on antimicrobial resistance concludes
thenews.com.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenews.com.pk Daily Mail and Mail on Sunday newspapers.
Workshop on antimicrobial resistance concludes
thenews.com.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenews.com.pk Daily Mail and Mail on Sunday newspapers.
Training held on monitoring of Covid immunisation affects
Islamabad
February 9, 2021
Islamabad:The Drug Regulatory Authority of Pakistan (DRAP), in collaboration with World Health Organisation, arranged a one-day training session on monitoring of Adverse Event Following Immunisation (AEFI) of COVID-19 vaccine here on Monday.
Representatives from the Pakistan National Pharmacovigilance Centre (PNPC), DRAP, federal and provincial Expanded Programmes on Immunization, and focal persons of pharmacovigilance from the provinces attended the training.
Dr. Abdur Rashid, Director, Division of Pharmacy and Head of PNPC welcomed the participants. He briefly explained the role of DRAP in general and the Division of Pharmacy Services in particular in the process of approval of clinical trials of COVID-19 vaccines in Pakistan and subsequent monitoring of AEFIs after their registration. He also explained the role and responsibilities of each stakeholder.
DRAP to hold training on reporting of COVID-19 vaccine adverse events
Published On
DRAP to hold training on reporting of COVID-19 vaccine adverse events
ISLAMABAD (Dunya News) - Drug Regulatory Authority of Pakistan’s (DRAP) Pakistan National Pharmacovigilance Centre (PNPC) in collaboration with the World Health Organization (WHO) have planned to arrange a day-long training on ‘reporting of COVID-19 vaccine adverse events’ here on Monday.
This training session is being arranged for capacity building of focal persons on adverse events following Corona vaccine from Punjab, Khyber Pakhtunkhwa, Balochistan, Sindh, Azad Jammu and Kashmir, Gilgit-Baltistan and Islamabad Capital Territory (ICT).
In Pakistan three Corona vaccines have been given emergency permission and for which 582 emergency vaccination centers have been established. In these centers physicians, pharmacists, nurses and other paramedics will be vaccinated.